Cancer
Scientists at the National Cancer Institute (NCI) have discovered that the HTLV-1 p13 protein alters mitochondrial biology and T-cell function, leading to chronic life-long infection. This research, published in the journal Viruses, found that p13 affects mitochondrial respiration and promotes the recruitment of CD4+ T cells, the primary target of
Cancer
Researchers at the University of Lahore have made significant findings in the study of apoptosis, a process of programmed cell death that plays a crucial role in cancer development and progression. According to a new report, the secretome from umbilical cord mesenchymal stem cells (UCMSCs) has been shown to inhibit
Cancer
Research conducted by investigators from the University of Debrecen, Hungary, has shed light on the prevalence and risk factors of malignancy in systemic sclerosis (SSc) patients. The study, published in the Journal of Biomedicines, revealed that SSc patients have a significantly higher risk of developing cancer, with skin cancer being
Cancer
SpotitEarly, a biotech startup, has launched in the U.S. market with a novel cancer detection technology that harnesses the power of artificial intelligence and canines to analyze volatile organic compounds in breath samples. The company has raised $20.3 million in funding and has attracted top investors, researchers, and
Cancer
A breast and cervical cancer screening and awareness camp was held at Bhopal Memorial Hospital and Research Centre (BMHRC) for gas-affected women, aiming to raise awareness about early diagnosis and prevention strategies. The camp included breast cancer screenings and Pap smear tests for cervical cancer detection, with gynaecologists speaking on
Cancer
A recent initiative aimed at promoting early detection of cancer has been hailed as a success. In a collaborative effort, the Balco Medical Centre, Naya Raipur, teamed up with Topworth Steels & Power Pvt. Ltd. to set up a one-day Free Cancer Screening Camp at the Primary Health Centre (PHC)
Cancer
Tempus AI, Inc. and Boehringer Ingelheim have entered a new strategic collaboration to accelerate the discovery and development of new treatments for hard-to-treat cancers. This multi-year agreement builds on the companies' existing partnership, leveraging data and artificial intelligence to drive therapeutic research and development. The collaboration aims to explore
Cancer
Neoantigen-based immunotherapy has emerged as a transformative approach in cancer treatment, offering precision medicine strategies that target tumor-specific antigens derived from genetic, transcriptomic, and proteomic alterations unique to cancer cells. According to researchers from Duke University, these neoantigens serve as highly specific targets for personalized therapies, promising more effective and
Cancer
A groundbreaking study from Rostock University Medical Center in Germany has shed new light on the relationship between cancer drivers and immune response. Researcher Rosaely Casalegno Garduno and colleagues have identified cancer heterogeneity as a significant challenge to immunotherapy, highlighting the need for improved biomarkers to predict treatment efficacy. The
Cancer
Researchers at Inner Mongolia University have published a new study highlighting the potential of gd T cells, a type of specialized T cell, in cancer treatment. The study focuses on the unique properties of gd T cells, including their ability to directly recognize and bind antigenic molecules without the need
Cancer
Lucey Lyne, an 18-year-old from Doncaster, has been battling Hodgkin Lymphoma since the age of 16. Despite undergoing intensive treatments, including 24 weeks of chemotherapy, four weeks of radiotherapy, and a stem cell transplant, Lucey relapsed and needed a donor transplant. Fortunately, a perfect stem cell match was found in
Cancer
Fiona Lott, a determined mother from Abergavenny, Wales, is fighting for a cure for brain cancer, a cause that has become deeply personal after her son Scott was diagnosed with a grade 2 astrocytoma in 2019. Scott, a health-conscious weightlifter and mountain climber, underwent debulking surgery, radiotherapy, and chemotherapy, but
